Spyre Therapeutics (SYRE) Files Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- S&P 500, Nasdaq climb as AI-linked stocks recover ahead of earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil slips from five-month high with Hormuz transits in focus
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| (NASDAQ: SYRE) | Delayed: 84.63 +4.73 (5.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.90 | 52 Week High | $ | |||
| Open | $82.29 | 52 Week Low | $ | |||
| Day High | $84.84 | P/E | N/A | |||
| Day Low | $80.94 | EPS | $ | |||
| Volume | 227,405 | |||||
